Physician profile
Mark Hansen
NPI 1689646507
$7,252.98
in general payments reported to CMS, 2019-2025
8 companies · $2,673 in 2025
The $2,673 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,289 · 2020: $15.86 · 2021: $55.70 · 2022: $79.89 · 2023: $66.42 · 2024: $72.53 · 2025: $2,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,617 · Education: $1,000 · Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,617.17 |
| Education | $1,000.00 |
| Food and Beverage | $195.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,966.27 | 2019-2025 | |
| Ethicon US, LLC | $77.82 | 2020-2024 | Harmonic, Echelon; Endopath, Enseal X1 |
| Medacta USA, INC. | $58.74 | 2019 | |
| Tela Bio, INC. | $51.43 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Merck Sharp & Dohme LLC | $37.78 | 2019-2022 | |
| Medtronic, INC. | $28.29 | 2022 | |
| W. L. Gore & Associates, INC. | $17.74 | 2024 | Gore Synecor Biomaterial |
| Integra Lifesciences Corporation | $14.91 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.